Standout Papers

Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemi... 2000 2026 2008 2017 1.3k
  1. Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias (2006)
    Moshe Talpaz, Neil P. Shah et al. New England Journal of Medicine
  2. Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL (2006)
    Hagop M. Kantarjian, Francis J. Giles et al. New England Journal of Medicine
  3. Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia (2000)
    Hagop M. Kantarjian, Susan O’Brien et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 17 from Science/Nature 63 standout
Sub-graph 1 of 18

Citing Papers

Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Acute lymphoblastic leukaemia
2020 Standout
7 intermediate papers

Works of Susan O’Brien being referenced

Kinase domain point mutations in Philadelphia chromosome‐positive acute lymphoblastic leukemia emerge after therapy with BCR‐ABL kinase inhibitors
2008
Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia
2000 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Susan O’Brien 3395 4258 1909 73 5.7k
Jianqin Shan 3784 6128 2165 79 7.2k
Mary Beth Rios 4913 6162 3413 129 7.3k
Gianantonio Rosti 4528 5567 2663 211 6.7k
Dragana Milojković 3545 4277 2097 134 5.3k
Gabriel Étienne 4198 5151 2425 108 6.0k
Jürgen Thiele 4775 6070 1736 71 8.6k
H. Kantarjian 2075 2398 764 117 3.8k
Joëlle Guilhot 2957 3377 1703 128 4.8k
Jaspal Kaeda 2747 3509 1844 68 4.2k
Neil P. Shah 5660 7097 3808 49 8.6k

All Works

Loading papers...

Rankless by CCL
2026